Decoding the Genetic Landscape of Skeletal Diseases

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorKarolinska Institutet

About this trial

This 5-year project aims to (1) search for genetic causes for yet unsolved congenital skeletal disorders (GSDs); (2) study consequences of the newly identified pathogenic variants in cells and in transgenic mice, (3) summarize data on natural course and complications for different GSD groups. For patients with unsolved GSD, the investigators search for molecular causes of GSDs using whole genome sequencing (WGS) and total ribonucleic acid (RNA) sequencing. Candidate gene variants are selected using genome or transcriptome sequencing data, clinical findings and screening of omics databases. Causality of the new variants is studied in cells and in transgenic mice models. Molecular and clinical findings are summarized for different GSD groups.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Individuals of any age with congenital skeletal diseases and their healthy relatives

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

New gene discoveries for genetic skeletal disorders (GSDs)

2-3 new disease causes and disease entities identified and reported per year for GSDs.

Time frame
2023-2028
2

Improved knowledge regarding natural cause of rare GSDs

1-2 GSDs reported as small patient groups with the same condition and clinical characteristics/course.

Time frame
2023-2028

Secondary outcomes

1

Disease (GSD) associated traits and complications

The observations include internal malformations, metabolic, biochemical and growth parameters, and secondary complications.

Time frame
2023-2028
2

Information on disease causing variants in GSD

During the study we identify several novel disease causing variants in known GSD genes and report them to databases.

Time frame
2023-2028

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Karolinska Institutet

Lead sponsor

Karolinska University Hospital

Collaborator

Göteborg University

Collaborator